This educational activity is partially supported by an educational grant/in-kind donation from Salix Pharmaceuticals.
Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases and disorders. We are focused on constantly innovating to improve patients’ lives.
We gain a deeper understanding of the GI conditions our products treat by connecting with the patients who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of expertise include overt hepatic encephalopathy, irritable bowel syndrome with diarrhea, irritable bowel syndrome with constipation, chronic idiopathic constipation, opioid-induced constipation, bowel preparation and ulcerative colitis.